Virbac shows 24% upside potential according to TP Icap
TP Icap Midcap analysts have attributed a 24% upside potential to Virbac shares versus current levels.
Published 13sem1 sourceupdated 2sem
Lire en français
≈ 20s
The fact
This bullish recommendation is based on a positive fundamental valuation of the French veterinary laboratory.
Analyst consensus reflects growth prospects in the animal health sector.
Click the link to read an article on the topic: